Literature DB >> 1747578

Haemorrhagic disease of the newborn in the British Isles: two year prospective study.

A W McNinch1, J H Tripp.   

Abstract

OBJECTIVE: To determine the incidence of haemorrhagic disease of the newborn in the British Isles, study risk factors, and examine the effect of vitamin K prophylaxis.
DESIGN: Prospective survey of all possible cases of haemorrhagic disease of the newborn as reported by consultant paediatricians using the monthly notification cards of the British Paediatric Surveillance Unit and a follow up questionnaire for each case to validate the diagnosis and accrue further data.
SETTING: Britain (England, Scotland, and Wales) and Ireland (Northern Ireland and the Irish Republic) during December 1987 to March 1990. PATIENTS: 27 infants classified as having confirmed (n = 25) or probable (n = 2) haemorrhagic disease of the newborn.
RESULTS: 24 of the 27 infants were solely breast fed. 10 suffered intracranial haemorrhage; two of these died and there was clinical concern about the remainder. 20 infants had received no vitamin K prophylaxis, and seven had received oral prophylaxis. Relative risk ratios for these groups compared with babies who had received intramuscular vitamin K were 81:1 and 13:1 respectively. Six infants had hepatitis (alpha 1 antitrypsin deficiency in four), unsuspected until presentation with haemorrhagic disease of the newborn, of whom four had received oral prophylaxis. One other baby had prolonged jaundice. One mother had taken phenytoin during pregnancy.
CONCLUSIONS: All newborn infants should receive vitamin K prophylaxis. Intramuscular vitamin K is more effective than oral prophylactic regimens currently used in the British Isles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747578      PMCID: PMC1671305          DOI: 10.1136/bmj.303.6810.1105

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

1.  Late haemorrhagic disease in Sweden 1987-89.

Authors:  H Ekelund
Journal:  Acta Paediatr Scand       Date:  1991-10

2.  Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom.

Authors:  J Handel; J H Tripp
Journal:  BMJ       Date:  1991-11-02

3.  The relation of vitamin K deficiency to hemorrhagic disease of the newborn.

Authors:  H DAM; H DYGGVE; H LARSEN; P PLUM
Journal:  Adv Pediatr       Date:  1952-01

4.  The British Paediatric Surveillance Unit.

Authors:  S M Hall; M Glickman
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

5.  Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

Authors:  K R Mountain; J Hirsh; A S Gallus
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

Review 6.  Vitamin K in infancy.

Authors:  R von Kries; M J Shearer; U Göbel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

7.  [Neonatal vitamin K prophylaxis and vitamin k deficiency hemorrhages in Switzerland 1986-1988].

Authors:  O Tönz; G Schubiger
Journal:  Schweiz Med Wochenschr       Date:  1988-11-26

8.  Factors associated with childhood cancer in a national cohort study.

Authors:  J Golding; M Paterson; L J Kinlen
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

  8 in total
  56 in total

1.  Six years' experience of prophylactic oral vitamin K.

Authors:  U Wariyar; S Hilton; J Pagan; W Tin; E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

Review 2.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

3.  Vitamin K and childhood cancer.

Authors:  D Hull
Journal:  BMJ       Date:  1992-08-08

4.  Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.

Authors:  E A Cornelissen; L A Kollée; R A De Abreu; J M van Baal; K Motohara; B Verbruggen; L A Monnens
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

5.  Vitamin K and childhood cancer.

Authors:  A W Kelsall
Journal:  BMJ       Date:  1992-10-24

Review 6.  Surveillance for rare disorders by the BPSU. The British Paediatric Surveillance Unit.

Authors:  C Verity; M Preece
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

7.  Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness.

Authors:  Alison Busfield; Andrew McNinch; John Tripp
Journal:  Arch Dis Child       Date:  2007-05-30       Impact factor: 3.791

8.  Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom.

Authors:  J Handel; J H Tripp
Journal:  BMJ       Date:  1991-11-02

Review 9.  The neonatal coagulation system and the vitamin K deficiency bleeding - a mini review.

Authors:  Ewald Pichler; Ludwig Pichler
Journal:  Wien Med Wochenschr       Date:  2008

10.  Neonatal vitamin K.

Authors:  R von Kries
Journal:  BMJ       Date:  1991-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.